Image

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

Comparing imaging methods for different neurological conditions in a clinical study.

Recruiting
18-85 years
All
Phase 2/3
This study investigates a new way to look at heart nerves with a special scan called **[18F]-MFBG PET**. It compares this scan to an older method, **[123I]-MIBG SPECT**, to see which is better at telling apart certain brain diseases. These diseases are **Parkinson's Disease (PD)**, **Multiple System Atrophy (MSA)**, **Dementia with Lewy Bodies (DLB)**, and **Alzheimer's Disease (AD)**. Participants will have to visit the hospital 3 to 4 times for different tests, including brain scans and heart scans. **Key Points:** 1. **Participation involves 3 to 4 hospital visits** for various scans and tests. 2. **No major health issues** like heart disease or diabetes, and participants must be non-smokers. 3. **Participants should be between 18 and 85 years old** and must understand and consent to the study. The study aims to see if the new scan can better distinguish between these diseases, possibly leading to earlier and more accurate treatment.
Study details
    Parkinson Disease
    Dementia With Lewy Bodies
    MSA - Multiple System Atrophy
    Alzheimer Disease

NCT06120049

prof. dr. Koen Van Laere

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.